Description
Dulaglutide is a GLP-1 receptor agonist built as a fusion protein: two GLP-1 analogue chains attached to an antibody Fc fragment, giving a once-weekly profile.
As an approved medicine elsewhere, it functions in research as a reference long-acting incretin, appearing in receptor-pharmacology comparisons and metabolic-model studies alongside the acylated analogues.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
